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Abstract
Background—Allergic sensitization is an important risk factor for the development of atopic
disease. The National Health and Nutrition Examination Survey (NHANES) 2005–2006 provides
the most comprehensive information on IgE-mediated sensitization in the general US population.
Objective—We investigated clustering, sociodemographic and regional patterns of allergic
sensitization and examined risk factors associated with IgE-mediated sensitization.
Methods—Data for this cross-sectional analysis were obtained from NHANES 2005–2006.
Participants aged ≥1 year (N=9440) were tested for sIgEs to inhalant and food allergens;
participants ≥6 years were tested for 19 sIgEs, and children aged 1–5 years for 9 sIgEs. Serum
samples were analyzed using the ImmunoCAP System. Information on demographics and
participant characteristics was collected by questionnaire.
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Results—Of the study population aged 6 and older, 44.6% had detectable sIgEs, while 36.2% of
children aged 1–5 years were sensitized to ≥1 allergen. Allergen-specific IgEs clustered into 7
groups that might have largely reflected biological cross-reactivity. Although sensitization to
individual allergens and allergen types showed regional variation, the overall prevalence of
sensitization did not differ across census regions, except in early childhood. In multivariate
modeling, young age, male gender, non-Hispanic black race/ethnicity, geographic location (census
region), and reported pet avoidance measures were most consistently associated with IgE-
mediated sensitization.
Conclusions—The overall prevalence of allergic sensitization does not vary across US census
regions, except in early life, although allergen-specific sensitization differs by sociodemographic
and regional factors. Biological cross-reactivity may be an important, but not a sole, contributor to
the clustering of allergen-specific IgEs.
Clinical implications—IgE-mediated sensitization shows clustering patterns and differs by
sociodemographic and regional factors, but the overall prevalence of sensitization may not vary
across US census regions.
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INTRODUCTION
The increased prevalence of allergic diseases is a major public health concern worldwide.1
In the United States (US), millions of people are affected by immunoglobulin E (IgE) –
mediated diseases, which not only impact the quality of life, but also place considerable
economic burden on patients and society.2, 3
The common hallmark of atopic disease is the production of specific IgE (sIgE) against
allergens. Assessment of sIgE antibodies with in vivo skin test challenges or in vitro
serologic analyses confirm allergic sensitization, while the patient’s clinical history and
physical examination remain important cornerstones of the diagnosis of atopic disease.4
Monitoring the prevalence and patterns of IgE-mediated sensitization in populations over
time is important because allergic sensitization is a significant risk factor for the
development of atopic disease.1 In the US, prevalence of allergic sensitization in the general
population has been estimated in three National Health and Nutrition Examination Surveys
(NHANES).5–8 In NHANES II (1976–1980) and III (1988–1994) allergy testing was
conducted by skin prick tests, whereas NHANES 2005–2006 measured sIgE levels in serum.
The NHANES 2005–2006 provides the largest and most recent nationally representative
data on IgE-mediated sensitization in the US population. Participants aged 6 years and older
were tested for 19 sIgE antibodies, and those ages 1–5 were tested for a subset of the
antibodies (9 sIgEs). The NHANES 2005–2006 not only tested a greater number of
allergens across a wider age range than the prior studies, but also provided quantitative
information on extent of allergic sensitization.
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This article provides a comprehensive report on clustering, sociodemographic and regional
patterns of allergic sensitization in the US population. Patterns of sensitization in NHANES
2005–2006 were compared with NHANES III data. We also identified factors independently
associated with IgE-mediated sensitization in the general population.
METHODS
Data
Data were obtained from NHANES 2005–2006, which is designed to assess the health and
nutritional status of the civilian, noninstitutionalized US population. The NHANES 2005–
2006, which includes 10,348 individuals, over-sampled persons of low-income, adolescents
12–19 years, persons 60 years of age and older, African Americans, and Mexican
Americans, in order to assure adequate samples for subgroup analyses. To protect
participant confidentiality, all data analysis using restricted, not publicly available, variables
(census region, level of urbanization) was conducted at the National Center for Health
Statistics (NCHS) Atlanta Research Data Center (RDC). The survey protocol was approved
by the NCHS Ethics Review Board,9 and written informed consent was obtained from all
participants. A detailed description of the survey design and methods is online at http://
www.cdc.gov/nchs/nhanes/nhanes2005_2006/nhanes05_06.htm.10 To examine sensitization
patterns over time, we used NHANES III data for comparisons. Study procedures and
methods for the NHANES III data have been previously described.7
Assessment of allergen-specific IgEs and atopy
Participants aged 1 year and older were eligible for serum IgE testing. Blood samples were
analyzed using the Pharmacia Diagnostics ImmunoCAP 1000 System (Kalamazoo,
Michigan), now known as Thermo Scientific™ ImmunoCAP Specific IgE. Participants aged
6 years and older were tested for allergen-specific IgE antibodies to 15 inhalant (i.e., indoor,
outdoor) allergens [Alternaria alternata, Aspergillus fumigatus, Bermuda grass (Cynodon
dactylon), birch (Betula verrucose), cat dander, cockroach (Blatella germanica), dog dander,
dust mite (Dermatophagoides farinae and D. pteronyssinus), mouse urine proteins, oak
(Quercus alba), ragweed (Ambrosia elatior), rat urine proteins, Russian thistle (Salsola
kali), rye grass (Lolium perenne)] and 4 food allergens [egg white, cow’s milk, peanut
(Arachis hypgaea), and shrimp (Pandalus borealis)]. Because of smaller quantities of
serum, the IgE panel for children under age 6 years was limited to 9 allergens [Alternaria
alternata, cat dander, cockroach (Blatella germanica), dog dander, dust mite
(Dermatophagoides farinae and D. pteronyssinus), egg white, cow’s milk, and peanut
(Arachis hypgaea)]. Of the participants 6 and older (N=8086), 89.9% (N=7268) had data for
all 19 specific IgEs, and of the children aged 1–5 years, 63.2% (N=856) had complete data
for the partial IgE panel.
The threshold for a positive test, which was considered indicative of sensitization, was the
level of detection (≥ 0.35 kUa/L). Subjects with at least 1 positive sIgE were considered
atopic. Detailed description of the laboratory procedures is presented elsewhere.11, 12
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Descriptive analyses and predictive modeling were performed using SAS (version 9.2, Cary,
NC) and SUDAAN (version 10.0, Research Triangle Park, NC). Cluster analysis was
conducted using the R system for statistical computing (version 2.10.1). To account for the
complex survey design, survey nonresponse, and post-stratification, sampling weights and
design variables were applied to all analyses (NHANES 205–2006, NHANES III) in order
to obtain unbiased national prevalence and variance estimates.
Participants aged 6 and older and 1–5 year olds were analyzed separately because of the
differences in IgE panels. Differences in the prevalence of positive allergen-specific IgE
tests by general population characteristics were tested with chi-square statistics. Among
atopic individuals, we used F-statistics to test differences in geometric mean (GM)
concentrations of sIgEs across population characteristic categories. When evaluating racial/
ethnic differences, we focused on the three main groups: non-Hispanic whites, non-Hispanic
blacks, and Mexican-Americans, excluding the group ‘others’ because of racial/ethnic
heterogeneity. To examine clustering of sIgEs, we used different statistical methods,
including hierarchical clustering, factor analysis, and multidimensional scaling.
We used logistic regression analysis to identify predictors of specific IgE positivity (i.e.,
sensitization) in the general population. For the predictor modeling, we used
sociodemographic and other characteristics associated with skin test positivity in NHANES
III.7 We also included reported pet avoidance measures because avoidance and/or removal
of pets because of allergy or asthma was strongly associated with the overall prevalence of
sensitization (data not shown). In the full model, we included age, gender, race/ethnicity,
poverty/income ratio, education, serum cotinine level, body mass index, year home
constructed, census region, level of urbanization, number of household members, household
crowding, presence of cats and/or dogs in the home, and reported pet avoidance, and used
backward elimination for model selection. All of the remaining predictors in the final model
had p-value ≤ 0.05. We also evaluated potential two-way interactions between age, gender,
and race/ethnicity, but no strong evidence for effect modification was found.
Sensitivity analyses were conducted to determine whether the modeling results were
influenced by using a different cut point for a positive serum IgE test. We also investigated
whether similar risk factors were associated with elevated sIgEs among atopic individuals.
We considered specific IgE levels elevated if any of the sIgE concentrations exceeded 17.5
kUa/L among subjects ages 6 and older and 3.5 kUa/L among the 1–5 year olds. The cut-
offs were not based on clinical relevance; however, they distinguished those with the highest
sIgE levels (<10%) among the atopic subjects. Since the additional analyses resulted in
similar results (data not shown), we present results only from the logistic regression using
the cutoff of 0.35 kUa/L for a positive test.
RESULTS
Prevalence and distributions of allergen-specific IgEs
Among the US population aged 6 years and older, 44.6% tested positive to at least one of the
19 allergens, and 36.2% of children aged 1–5 were sensitized to at least one of the 9
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allergens tested. The median number of positive tests was 3 among those 6 and older, and 2
among 1–5 year olds. Figure 1 illustrates the prevalence of positive tests and distributions of
sIgE concentrations in the US population. Among those 6 and older, the prevalence of a
positive IgE test varied from 1.1% (mouse) to 19.5% (rye grass). Sensitization to any indoor
and any outdoor allergens was equally common (30%) and more prevalent than sensitization
to foods (16.2%) (Table E1 Online Repository). Prevalence of food sensitization (28%) was
significantly higher among children younger than 6 years than in older age groups, as
previously reported.13 Detailed data on sIgEs, including prevalences and geometric means
(GMs), are presented in the Online Repository (Tables E1, E2, E3, and E4).
Clustering of positive IgE tests
We previously reported in abstract form that the 19 specific IgEs group into clusters;14
Figure 2 illustrates details from the cluster analysis. The dust mite-specific IgEs were most
highly correlated (Pearson correlation coefficient of 0.97). In the plant cluster, grass- and
tree-specific IgEs, and in the pet cluster, cat- and dog-specific IgEs were also highly
correlated (Pearson correlation coefficients ≥ 0.78). Of those aged 6 years and older, 27.1%
were sensitized to plant-related (grass-, tree, weed-, and peanut-specific) allergens; 20.3% to
dust mites (D. farinae and D. pteronyssinus); 15.7% to pets (dog, cat); 11.7% to cockroach
and/or shrimp; 10.4% to molds (Alternaria, Aspergillus); 6.6% to egg white and/or cow’s
milk; and 1.8% to rodents (mouse, rat). The percentage of the population with positive
cluster responses decreased with increasing number of the clusters. Among those 6 and
older, 19.8% had positive responses originating from 1 cluster, and 10.8% from 2, 7.4%
from 3, 3.9% from 4, 1.8% from 5, 0.6% from 6, and 0.2% from 7 clusters.
Demographic characteristics of allergic sensitization
The prevalence of allergic sensitization differed significantly by age for each of the tested
allergens except for rat. For inhalant allergens, prevalence of sensitization generally peaked
in the second or third decades of life and declined towards late adulthood (Fig 3). In
contrast, sensitization to milk and egg was most prevalent among 1–5 year olds, but declined
sharply after age 6 throughout childhood.
Overall, the prevalence of allergic sensitization was higher in males than in females (Fig 4),
but the difference was not always present at each age category (Fig E1 Online Repository).
Among the youngest age group (1–5 year olds) greatest gender differences were seen for pet
allergens, especially for cat.
The prevalence of allergic sensitization to all types of allergens varied significantly by race-
ethnicity (Fig 4). Among those 6 and older, non-Hispanic blacks had the highest prevalence
of sensitization to all tested allergens, except for Russian thistle and egg. Among 1–5 year
olds, allergic sensitization tended to be less prevalent in non-Hispanic whites than in other
race/ethnic groups, although differences did not always reach statistical significance for
individual sIgEs. Figure E2 in the Online Repository illustrates race/ethnic variation by age.
Socioeconomic patterns of allergic sensitization were less consistent (Fig 4). However,
sensitization to German cockroach and shrimp were associated with indicators of lower
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socioeconomic status (SES), whereas sensitization to dog and cat allergens was more
prevalent among higher SES groups. Although sensitization to outdoor allergens was more
prevalent in higher SES groups, most differences were not statistically significant.
Differences in allergic sensitization across levels of urbanization
Among those 6 and older, sensitization to allergens was more prevalent in metropolitan
areas than in less urbanized areas (Fig 4). In central metropolitan areas (population ≥ 1
million), 50.0% of the population, was sensitized to at least one allergen, whereas in non-
metropolitan areas the prevalence of sensitization was less than 40.0% (Table E1). The most
consistent associations were observed for outdoor allergens; in large, central metropolitan
areas, 37.8% was sensitized to outdoor allergens, while less than one-fourth (22.9–24.9%) of
the non-metropolitan population was sensitized to outdoor allergens. Among 1–5 year olds,
sensitization to all types of allergens was more prevalent in large metropolitan areas than
other areas, but none of the differences were statistically significant (Table E3).
Differences in allergic sensitization across census regions
Although the overall prevalence of sensitization did not differ significantly by census region,
there were regional differences for individual allergens and allergen types (Fig 5, Tables E1,
E3). Sensitization to indoor allergens, was most prevalent in the South (34.5% among 6 and
older, 26.5% among 1–5 year olds), in particular to dust mite and cockroach allergens. For
most outdoor allergens, prevalence of sensitization was highest in the West (36.0%),
especially for Russian thistle (17.9%) and grasses (21.4–25.0%). Among those 6 and older,
sensitization to food allergens was most prevalent in the South. Of the food-specific IgEs,
only peanut in the 6 and older group showed regional variation (Tables E1, E3).
Concentrations of allergen-specific IgE
The GMs of the sIgE concentrations (kUa/L) ranged from 0.74 (egg) to 3.89 (rye grass)
among persons with a positive test to the specific allergen (Tables E2 and E4). Levels of
sIgEs tended to decrease with increasing age group, after peaking in childhood and early
adulthood. The majority of the GMs did not differ significantly by gender. Among those 6
and older, non-Hispanic blacks did not always have the highest levels of sIgE, but the GMs
of dust mite-, cockroach-, mold-, and shrimp-specific IgEs were significantly higher in non-
Hispanic blacks than in other groups. Among 1–5 year olds, only cockroach-specific IgE
levels were lower in non-Hispanic whites than in other groups. Across all age groups, lower
SES was consistently associated with higher cockroach-specific IgE levels. While the level
of urbanization was not associated with sIgE levels in early years of life, except for peanut,
levels of several sIgEs (i.e., pet-, cockroach-, weed-, tree-, mold-, shrimp- and peanut-
specific IgEs) in the older age groups varied significantly across urbanization levels.
Variation across census regions was apparent for indoor- and outdoor- specific IgE
concentrations, but not for food-specific IgE levels.
Predictors of allergic sensitization
Table I shows participant characteristics that were independently associated with 1 or more
positive test responses (A subjects aged 6 and older; B 1–5 year old children). The odds of
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specific IgE positivity increased throughout childhood and early adulthood, and were
consistently higher among males (except in early years of life), among non-Hispanic blacks,
and among those who reported avoidance and/or removal of pets. Although the odds of
specific IgE positivity were highest in the South in early childhood, no significant regional
differences were found in older age groups. Age, gender, race/ethnicity and census region
were also consistently associated with elevated sIgE levels among atopic individuals (data
not shown).
Comparisons between NHANES 2005–2006 and NHANES III
In NHANES 2005–2006, grass, dust mite, and ragweed allergens were the most common
sensitizers among subjects aged ≥ 6 years, consistent with NHANES III.7 Figures E3–E5 in
the Online Repository illustrate similar patterns of allergic sensitization by age, gender, and
race/ethnicity in both surveys. In contrast, patterns of sensitization across census regions
showed greater variability in NHANES 2005–2006; regional variation was observed for all
types of allergens (Tables E1, E3) in NHANES 2005–2006, whereas only sensitization to
outdoor allergens varied by census region in NHANES III.7 The overall prevalence of
sensitization did not vary across census regions in NHANES 2005–2006 as it did in
NHANES III.
DISCUSSION
The NHANES 2005–2006 provides the most detailed information on IgE-mediated
sensitization in the US population, including quantitative information on extent of allergic
sensitization. It is the first nationwide study to examine allergic sensitization from early
years of life (children aged 1–5 years) to old age (aged ≥ 75 years). Almost half of the US
population 6 and older and more than one third of children aged 1–5 had positive sIgE
responses to at least one allergen. In NHANES 2005–2006, allergen-specific IgEs clustered
into 7 biologically relevant groups. Across the US, sensitization to individual allergens and
allergen types showed regional variation, whereas the overall prevalence of sensitization did
not, except in early years of life. In multivariate models, age, gender, race/ethnicity, census
region, and reported pet avoidance measures were consistently associated with IgE-mediated
sensitization, although gender differences were less pronounced in early life.
The NHANES 2005–2006 data offered a unique opportunity to explore clustering of sIgEs
in the general US population. Although IgE-mediated allergy is known to aggregate in
clusters of allergens;15, 16 few population-based studies have examined clustering patterns.
Structural similarity of allergenic epitopes, the major determinant of cross-reactivity,17
might be a key contributor to the clustering. However, sIgE patterns may also reflect
individual’s propensity to co-exposure/sensitization that can occur without sequence
homology and/or common epitopes (e.g., egg- and milk-sIgEs).17, 18 As expected, highest
correlations were observed for dust mite-, grass- and tree-specific allergens, which share
groups of cross-reactive allergens.17 The clustering of cockroach and shrimp-specific IgEs
may reflect indirect sensitization to a cross-reactive allergen, tropomyosin. In a recent study,
the correlation between cockroach- and shrimp-specific allergens among inner-city children
was associated with residential exposure to cockroach allergen.19 Although peanut is
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traditionally considered a food allergen, it was not surprising that peanut-specific IgE
grouped together with plant-specific IgEs, because peanut allergens show extensive IgE
cross-reactivity between homologous pollen allergens.20, 21 Studies have shown that peanut-
sensitized individuals are often also sensitized to pollens.21, 22 Consistent with the previous
reports,21, 22 sensitization to plant-related allergens was highly prevalent among peanut-
sensitized NHANES 2005–2006 participants. The vast majority of those with positive test
response to peanut were sensitized to grass- (88.7%), tree- (88.6%) or weed-specific
(90.6%) allergens (data not shown). However, a large proportion of serological cross-
reactivity may not be clinically relevant. For example, a recent study showed that children
sensitized to both peanut and birch were less likely to report symptoms to peanut than those
who were sensitized to peanut, but not to birch pollen.21
In NHANES 2005–2006, the patterns of sensitization across sociodemographic factors were
similar to previous NHANES reports.7, 8 IgE-mediated sensitization was strongly associated
with age. The prevalence and levels of inhalant allergen-specific IgEs peaked in childhood
and early adulthood, whereas sensitization to foods (i.e., milk and egg) was most prevalent
prior to age 6.13 The declining trends in the prevalence of sensitization and sIgE levels in
older age groups may reflect changes in the immune system that accompany aging. Studies
have demonstrated age-associated alterations in many aspects of immune function (e.g., T-
and B-cell functions), although immunosenescence may vary by the atopic phenotype.23, 24
Gender differences in prevalence are common in atopic disorders.25 Although gender-
specific differences in immune responses emerge in early childhood, the clinical expression
and diagnostic markers of atopic disease are influenced by genetic, hormonal, and
environmental factors throughout life.26, 27 In NHANES 2005–2006, males were more
likely to have positive sIgE tests as well as elevated levels of sIgEs than females, except
among 1–5 year olds. Some studies have suggested that differences in the production of IgE
may be associated with gender-related genetic differences in IgE control.28
The NHANES 2005–2006 data demonstrated racial/ethnic differences from infancy. Among
1–5 year olds, sensitization to allergens - particularly, sensitization to food allergens that
often precedes the progression of allergic diseases29 - was significantly lower in non-
Hispanic whites than other race/ethnic groups. Among those 6 and older, non-Hispanic
blacks were most likely to have positive test responses and to have elevated levels of sIgEs.
Although several studies have reported racial and ethnic disparities in prevalence of allergic
sensitization, there is limited information on how genetic, socioeconomic, cultural,
environmental or other factors contribute to the observed disparities.30 A recent study
suggested that the racial disparity might primarily result from environmental rather than
genetic factors.31
Although many large epidemiological studies have reported substantial geographical
variation in the prevalence of sensitization,7, 32, 33 the overall prevalence of allergic
sensitization did not vary regionally in NHANES 2005–2006, except in early life. In
population-based studies, atopy is often assessed using test panels limited to inhalant
allergens,32, 33 whereas in NHANES 2005–2006, the panel consisted of a variety of indoor,
outdoor and food allergens. The use of a larger test panel may have influenced the
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sensitivity of the assessment of allergic sensitization. Even though the majority of the
outdoor allergens showed significant regional variability in sensitization patterns, the panel
included several allergens (e.g., pets, rodents, ragweed, molds, and most foods) that did not
show variation by region. In NHANES 2005–2006, chances of capturing mono-sensitized
individuals may have been increased because egg and milk were the most common
sensitizers among mono-sensitized participants (data not shown). In contrast, in NHANES
III, the regional variation in the overall prevalence of sensitization may have reflected higher
sensitization rates to outdoor allergens in the Western US. The majority of the tested
allergens in NHANES III were outdoor allergens, of which many had significantly higher
sensitization rates in the West (e.g., grasses, Russian thistle). The overall prevalence of
sensitization, however, may vary geographically in early life. Among 1–5 year old
NHANES 2005–2006 participants, those living in the South were most likely to have
positive sIgE responses. Differences in indoor allergen sensitization rates may contribute to
the regional variation in this age group, because sensitization to dust mite and cockroach
allergens was significantly higher in the South compared to the other census regions.
Although regional differences were also observed in sIgE levels, caution is warranted when
interpreting the results of the youngest age group because of highly variable sIgE
concentrations and a small sample size. Among atopic individuals aged 6 years and older,
grass-specific IgEs reached particularly high levels in the West.
Pet avoidance, reported avoidance and/or removal of pets from home because of allergies or
asthma, was strongly associated with positive sIgE responses and elevated levels of specific
IgEs. Although the relationship between the development of atopic disorders and exposure
to pets and pet allergens remains controversial,34–36 pet allergens are triggers for many
atopic individuals and can influence disease severity among sensitized patients.37–39
Individuals or families with allergies often avoid owning pets, either because pets trigger
symptoms or as a precaution. Studies report that higher parental awareness of risk factors for
allergic disease can influence the likelihood of pet avoidance.40 Because this study is cross-
sectional, participants may have modified their behavior due to their atopic status. Thus, the
interpretation of pet related associations is complicated. Although associations are adjusted
for pet avoidance measures, the data may not have captured avoidance measures throughout
life. The inverse association between sensitization and the presence of cat(s) may be
partially explained by reverse causation; sensitization precedes and causes the absence of
cats. Atopic individuals might have been more likely to remove cats than dogs from home.
In NHANES 2005–2006, only 34.0% of those who removed a cat from home in the past 12
months were sensitized to cat allergen, whereas almost half (48.4%) of those who removed a
dog were sensitized to dog allergen (data not shown). Studies suggest that selective
avoidance is often more common to cats than dogs.40, 41
Although several studies have reported an inverse association between smoking and
atopy, 7, 32, 42 the association of smoking on allergic sensitization has been inconsistent in
the literature.43 The inverse association may either reflect selective avoidance of smoking or
immuno-suppressive effects of tobacco smoke. 42, 44 Some studies report that those with
asthma and allergies in childhood are less likely to initiate smoking than their healthy
peers.44
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Allergic sensitization was more prevalent in large, central metropolitan areas compared to
other areas. Supporting the existing literature,8, 45 differences were most consistent for
outdoor allergens. Level of urbanization was not an independent predictor in the logistic
regression models, perhaps due to lesser variation of other types of sIgEs. Microclimatic
differences associated with urbanization, most notably a CO2 concentration and temperature
increase, have been associated with faster growth, earlier flowering, and greater
aboveground biomass and pollen production of plants (e.g., ragweed) in urban areas
compared to rural locations.46 Numerous studies report that plant-related aeroallergen
exposures are influenced by increasing CO2 concentrations, climate change, or both, leading
to longer pollen seasons, greater pollen loads, and changes in allergenicity and spatial
distributions of allergens.47, 48 Data also demonstrate complex interactions between urban
air pollution, aeroallergens, and allergic diseases; air pollution may not only contribute to
the etiology of some atopic disorders but may also modify the effect of aeroallergens on
atopic diseases.49, 50 Recent nationally representative studies report that respiratory allergies
are positively associated with air pollution in the US.51, 52 It is also possible that differences
across levels of urbanization reflect other environmental effects; many studies have reported
protective effects of growing up in a farming environment from the subsequent development
of atopic disorders.53, 54
The cross-sectional design of NHANES 2005–2006 precludes the assessment of temporal
relationships. Further, the presence of allergen-specific IgE antibodies does not necessarily
correspond to clinical allergy (i.e., symptoms), but multiple studies have demonstrated that
the likelihood of clinical allergy correlates with the results from allergy testing.55–57 The
methodological differences between NHANES 2005–2006 and previous NHANES studies
make it difficult to compare population-based prevalence of allergic sensitization over time.
Because the performance characteristics of serum-specific IgE and skin prick tests
vary,58, 59 results from these two tests are not interchangeable. For example, cockroach has
substantially lower sensitivity when performance characteristics of ImmunoCAP are
compared to skin prick tests.58 Although the sensitivity of the assay has improved over the
past decade, we were not able to evaluate sensitization below the cut-off of 0.35 kUa/L,
which may be suboptimal.60 Due to missing sIgE data, the small sample size of the youngest
participants likely compromised statistical power in subgroup analyses. Despite these
limitations, NHANES 2005–2006 extends the knowledge on allergic sensitization in the US
population; none of the previous surveys have examined quantitative sensitization patterns
and used this many allergens across participants from infancy to old age.
In summary, a large portion of the US population is sensitized to indoor, outdoor and food
allergens. Sensitization showed clustering patterns that might have largely reflected
biological cross-reactivity. Although the overall prevalence of sensitization did not vary
across census regions, except in early life, the NHANES 2005–2006 data demonstrated
regional differences in the prevalence of sensitization to individual allergens and allergen
types. Positive sIgE responses and elevated levels of sIgEs were most consistently
associated with age, gender, race/ethnicity, census region, and reported pet avoidance
measures. The NHANES 2005–2006 provides valuable information on IgE-mediated
sensitization patterns in the US population, highlighting the sociodemographic and regional
variability of allergic sensitization.
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Prevalence of positive serum IgE tests and distributions of the allergen-specific antibody
concentrations in the US population (A, B: Subjects aged 6 years and older; C,D: Subjects
aged 1–5 years). Box plots display the minimum and maximum values and the 25th, 50th,
and 75th percentiles. The measuring range was 0.35–1000 kUa/L.
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Clustering of the allergen-specific IgEs. The dendrogram (right) employs hierarchical
clustering to group similar sIgEs based on the log-transformed correlation matrix (left).
Hierarchical cluster analysis identified 7 IgE clusters: 1) plants (grass-, tree-, weed-, and
peanut-specific IgEs); 2) dust mites (D. farinae and D. pteronyssinus); 3) pets (dog and cat);
4) cockroach and shrimp; 5) molds (Alternaria and Aspergillus); 6) foods (egg white, cow’s
milk); and 7) rodents (mouse and rat).
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Prevalence of positive serum IgE tests by age among the US population. Solid symbols
represent statistically significant differences, whereas prevalences that are not statistically
different are marked with open symbols. Red symbols indicate the subgroup of allergens
that were measured in 1–5 year old children.
Salo et al. Page 22























Prevalence of positive serum IgE tests by demographic characteristics in the US population
(A: Subjects aged 6 years and older; B: Subjects aged 1–5 years). Solid symbols represent
statistically significant differences, whereas prevalences that are not statistically different are
marked with open symbols.
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Prevalence of positive serum IgE tests by census region in the US population (A: Subjects
aged 6 years and older; B: Subjects aged 1–5 years).
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TABLE I
Prevalences and odds ratios for the independent predictors of specific IgE positivity in the NHANES 2005–








A. Subjects 6 and older
Age group <0.001
  6–9 46.7 (2.87) 1.8 (1.1–2.9)
  10–19 48.7 (1.48) 2.1 (1.5–3.0)
  20–29 52.1 (2.46) 2.6 (1.8–3.7)
  30–39 51.6 (2.96) 2.5 (1.6–4.0)
  40–49 45.3 (1.79) 1.9 (1.4–2.6)
  50–59 38.2 (2.37) 1.5 (1.1–1.9)
  60–69 39.4 (2.84) 1.6 (1.1–2.3)
  70–79 28.2 (2.27) 0.9 (0.6–1.4)
  80+ 28.6 (3.29) 1.0 (reference)
Gender <0.001
  Female 39.8 (1.31) 1.0 (reference)
  Male 49.8 (1.40) 1.6 (1.4–1.8)
Race/ethnicity <0.001
  Non-Hispanic White 41.6 (1.25) 1.0 (reference)
  Non-Hispanic Black 57.4 (1.55) 1.9 (1.5–2. 4)
  Mexican American 46.5 (1.59) 1.0 (0.8–1.3)
  Other 49.8 (3.42) 1.3 (1.0–1.7)
Presence of cat(s) 0.010
  No 46.2 (1.01) 1.0 (reference)
  Yes 40.0 (2.39) 0.8 (0.7–1.0)
Presence of dog(s) 0.049
  No 44.3 (1.47) 1.0 (reference)
  Yes 45.2 (1.27) 1.2 (1.0–1.4)
Pet avoidance <0.001
  No 42.9 (1.23) 1.0 (reference)
  Yes 69.5 (3.24) 3.2 (2.4–4.4)
Serum cotinine (ng/ml) <0.001
  0.011 (< LOD) 44.8 (2.85) 1.0 (reference)
  0.035–0.100 44.7 (1.58) 0.9 (0.7–1.1)
  0.100–10.00 47.0 (1.72) 0.8 (0.6–1.1)
  10.00–1156.0 42.5 (1.18) 0.7 (0.6–0.9)
B. Subjects aged 1–5 years
Race/ethnicity <0.001
  Non-Hispanic White 28.9 (2.00) 1.0 (reference)
  Non-Hispanic Black 47.9 (3.13) 2.0 (1.6–2.6)
  Mexican American 41.9 (3.21) 1.9 (1.4–2.5)






























  Other 49.9 (5.49) 2.7 (1.7–4.1)
Census region 0.008
  Midwest 30.8 (2.38) 1.0 (reference)
  Northeast 32.5 (2.42) 1.0 (0.7–1.4)
  South 45.3 (4.08) 1.6 (1.1–2.3)
  West 32.0 (2.90) 0.8 (0.6–1.1)
Pet avoidance 0.034
  No 35.4 (1.53) 1.0 (reference)
  Yes 58.1 (9.92) 2.6 (1.1–6.3)
*
Atopy: among subjects 6 and older, having detectable levels (≥ 0.35 kUa/L) of specific IgE to any of the 19 allergens; among children 1–5 years
old, having detectable levels of specific IgE to any of the 9 allergens tested in this age group
†
Adjusted for each variable in the tables A and B
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